过去一年中添加的文章，按日期排序

Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies

D Pantazi, D Alivertis, AD Tselepis - … Treatment Options in Oncology, 2024 - Springer
30 天前 - … NETs are involved in venous thrombosis in patients with pancreatic cancer [83]. …
direct oral anticoagulants (DOACs), cancer patient may benefit more from novel anticoagulants …
相关文章 所有 3 个版本
[HTML] mdpi.com

[HTML][HTML] Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey

M Mongelli, D Lorusso, V Zanagnolo, S Pignata… - Diagnostics, 2024 - mdpi.com
42 天前 - … Direct oral anticoagulants (DOACs), such as rivaroxaban and apixaban, are
accepted as an alternative treatment for cancer-associated thromboembolisms [23]. DOACs have …
相关文章 所有 3 个版本

A retrospective review of recurrent venous thromboembolism in patients with cancer with direct factor Xa inhibitors.

S Fitzgerald, AP Dean, A Das, I O'Donnell, M Ibraheem… - 2024 - ascopubs.org
43 天前 - … patients who have developed thromboembolic events whilst on direct oral
anticoagulation… Methods: Electronic patient records were reviewed for oncology patients attending …
相关文章

Efficacy of low-dose direct oral anticoagulants (DOACs) for venous thromboembolism prophylaxis in newly diagnosed multiple myeloma.

D Basali, H Zureigat, DP Nurse, H Elmaleh, H Batah… - 2024 - ascopubs.org
44 天前 - … Background: The venous thromboembolism (VTE) risk is high in newly
diagnosed multiple myeloma (NDMM) patients, especially within 6 months of beginning …
相关文章

Incidence of venous thromboembolism in newly diagnosed glioblastoma multiforme and associated risk factors: A retrospective chart review.

N Al Majarafi, DO Binjabal, GR Pond, HW Hirte - 2024 - ascopubs.org
44 天前 - … Conclusions: Newly diagnosed patients with GBM have been shown to have a …
the preventive benefit of administering a direct oral anticoagulant (DOAC) to cancer patients, …
相关文章

Efficacy and safety of DOACs versus LMWH for elderly patients with active cancer: A meta-analysis.

A Marinho, MC Caldeira de Freitas, G Coelho Itaya… - 2024 - ascopubs.org
44 天前 - … aims to reduce the high risk of thromboembolism. Direct oral anticoagulants (DOACs) …
) are currently approved for the treatment of cancer-related thrombosis. However, there is …
相关文章

Real-world data of cancer-associated venous thromboembolism in a tertiary-care hospital in India.

M Mahapatra, P Upadhaya, M Aggarwal, J Dass… - 2024 - ascopubs.org
44 天前 - … Prophylactic anticoagulation is under-utilized and the cost of low- molecular-weight
heparin (LMWH) and direct oral anticoagulants is a major barrier in developing countries. …
相关文章
[HTML] eco-vector.com

Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients

AR Kasimova, AS Kolbin - Therapy, 2024 - journals.eco-vector.com
45 天前 - … drugs from the group of direct oral anticoagulants in the prevention of DVT and PE
… treatment and prevention of venous thromboembolism in the general population and patients …
相关文章

Evaluation of acute thrombus regression effect of edoxaban for deep vein thrombosis in patients with cancer: a single-center prospective observational study

S Hisatake, S Kiuchi, S Dobashi, Y Murakami, T Ikeda - Heart and Vessels, 2024 - Springer
52 天前 - … anticoagulants, from the previous vitamin K antagonists to direct oral anticoagulants
(… Europe, the use of DOACs is recommended for patients with cancer-related VTE [9,10,…
相关文章 所有 3 个版本

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

M Di Nisio, M Candeloro, N Potere, E Porreca… - Bleeding, Thrombosis …, 2024 - btvb.org
57 天前 - … Venous thromboembolism (VTE) is a relatively common complication in cancer
patients … most often used are low-molecular-weight heparin (LMWH) and direct oral factor (F) Xa …
相关文章